New therapeutic agents in diabetic nephropathy
Yaeni Kim, Cheol Whee Park
Korean J Intern Med. 2017;32(1):11-25.   Published online 2017 Jan 1     DOI: https://doi.org/10.3904/kjim.2016.174
Citations to this article as recorded by Crossref logo
Tannins and vascular complications of Diabetes: An update
Ankit P. Laddha, Yogesh A. Kulkarni
Phytomedicine.2019; 56: 229.     CrossRef
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy
Massimo Dal Monte, Maurizio Cammalleri, Valeria Pecci, Monica Carmosino, Giuseppe Procino, Alessandro Pini, Mario De Rosa, Vincenzo Pavone, Maria Svelto, Paola Bagnoli
Journal of Cellular and Molecular Medicine.2019; 23(2): 1034.     CrossRef
Diabetic nephropathy: An update on pathogenesis and drug development
Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754.     CrossRef
Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways
Lan Yao, Jie Li, Linlin Li, Xinxia Li, Rui Zhang, Yujie Zhang, Xinmin Mao
BMC Complementary and Alternative Medicine.2019;[Epub]     CrossRef
Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
Himanshu Sankrityayan, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Pharmacological Research.2019; 141: 574.     CrossRef
CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
Meng-Yao Sun, Su-Juan Wang, Xiao-Qin Li, Yu-Li Shen, Jian-Rao Lu, Xin-Hui Tian, Khalid Rahman, Li-Jun Zhang, Hua Nian, Hong Zhang
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
Yaeni Kim, Cheol Whee Park
International Journal of Molecular Sciences.2019; 20(7): 1782.     CrossRef
Adiponectin for the treatment of diabetic nephropathy
Jun Young Lee, Jae Won Yang, Byoung Geun Han, Seung Ok Choi, Jae Seok Kim
The Korean Journal of Internal Medicine.2019; 34(3): 480.     CrossRef
Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract
Xianrong Lai, Dong Tong, Xiaopeng Ai, Jiasi Wu, Yu Luo, Fang Zuo, Zhicheng Wei, Yanqiao Li, Wanyi Huang, Wenqian Wang, Qing Jiang, Xianli Meng, Yong Zeng, Ping Wang
Scientific Reports.2018;[Epub]     CrossRef
Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
Hwajin Kim, Theodomir Dusabimana, So Kim, Jihyun Je, Kyuho Jeong, Min Kang, Kye Cho, Hye Kim, Sang Park
Nutrients.2018; 10(11): 1703.     CrossRef
Role of incretin based therapies in the treatment of diabetic kidney disease
Paola Fioretto, Andrea Frascati
Diabetes mellitus.2018; 21(5): 395.     CrossRef
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
Zubair Ilyas, Joumana T. Chaiban, Armand Krikorian
Reviews in Endocrine and Metabolic Disorders.2017; 18(1): 21.     CrossRef
Comment on “New therapeutic agents in diabetic nephropathy”
Alain Gay, Peter Kolkhof
The Korean Journal of Internal Medicine.2017; 32(3): 569.     CrossRef
Brazilin Ameliorates Diabetic Nephropathy and Inflammation in db/db Mice
Zhan-yuan Li, Yu Zheng, Yan Chen, Min Pan, Shu-bei Zheng, Wen Huang, Zhi-hong Zhou, Han-yang Ye
Inflammation.2017; 40(4): 1365.     CrossRef
Response to comment on “New therapeutic agents in diabetic nephropathy”
Yaeni Kim, Cheol Whee Park
The Korean Journal of Internal Medicine.2017; 32(3): 570.     CrossRef
Treatment of diabetic kidney disease: current and future targets
Mi-Kyung Kim
The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef